24/7 Wall St. on MSN
Abbott Labs vs. Danaher: Abbott’s everyday products beat Danaher’s slumping biotech equipment
Quick ReadAbbott (ABT) outpaced Danaher (DHR) as FreeStyle Libre delivered $2.08B while Cepheid respiratory revenue fell 25% on a soft flu season.Danaher's bioprocessing equipment orders surged over ...
Abbott Laboratories’ sales of COVID-19 tests fell by a whopping 89% during the second quarter of this year compared with the same time last year — a drop that comes as the world attempts to move on ...
The test, run on Abbott's portable i-STAT® Alinity® instrument, uses whole blood to help evaluate patients with a suspected mild traumatic brain injury (mTBI), or concussion The test produces ...
By Sahil Pandey June 24 (Reuters) - ALZpath said on Wednesday it had signed a global licensing agreement with Abbott ...
A new study suggests that the Covid-19 diagnostic test being used by the White House frequently misses cases of the virus. The Abbott ID NOW test, which has been touted by President Trump on several ...
(Reuters) - The U.S. Food and Drug Administration said on Thursday that Abbott Laboratories’ speedy coronavirus test, which can deliver results within minutes and is used at the White House, could ...
Abbott has scored yet another Emergency Use Authorization for rapid coronavirus testing – this one, named BinaxNOW COVID-19 Ag Card, come in the form of a card and can provide results in 15 minutes.
Shares of Abbott Laboratories popped after the company's earnings and revenue topped Wall Street estimates, defying a dramatic slowdown in sales of its Covid tests. The results were driven in part to ...
Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories is rebounding from last year’s manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results